SAN DIEGO, March 12, 2026 /PRNewswire/ — Kenai Therapeutics, a clinical-stage biotechnology company pioneering next...
2026
Approved for Use By both the World Health Organization’s International Nonproprietary Names (WHO-INN) and the...
SALT LAKE CITY, March 12, 2026 /PRNewswire/ — Co-Diagnostics, Inc. (Nasdaq: CODX) (“Co-Dx” or “the...
Vistagen Therapeutics is doubling down on its lead social anxiety candidate, even after the asset...
Amid growing regulatory pressures, including IRA pricing reforms, RevSavvy reports increasing adoption of its ARC...
SAN DIEGO, March 12, 2026 /PRNewswire/ — Halozyme Therapeutics, Inc. (NASDAQ: HALO) (“Halozyme” or the “Company”)...
SAN FRANCISCO a CHANG-ČOU, Čína, 12. března 2026 /PRNewswire/ – S tím, jak umělá inteligence...
DOMA Perpetual Nominates Three Highly Qualified Candidates for the Board of Pacira BioSciences, Inc.
DOMA Perpetual Capital Management LLC (PRNewsfoto/DOMA Perpetual) Pacira’s Stock is Down 56% Over the Last...
Three of the top diabetes tech companies put forward new clinical data this week, making...
New research advances genetic diagnosis Demonstrates the potential to expand equitable access to treatment for...